Pharma & Nutraceutical Biz Looking For Part Exit In Guwahati

About Business

The pharmaceutical business is engaged in developing, manufacturing and supplying generic pharmaceutical and nutraceutical products. The business has an established presence in the North East market, with operations currently covering Assam, Tripura and Mizoram, along with a broader distribution network.

The company has its own product portfolio of 13 SKUs across generic medicines, common allopathic products and nutraceuticals. Manufacturing of the products is currently carried out through third-party manufacturing facilities located across different parts of India.

Product Portfolio

- Generic pharmaceutical products.
- Common allopathic medicines.
- Nutraceutical and vitamin-based products.
- Capsules, tablets and syrup formulations.
- Products focused on areas including general healthcare, nutrition and women's health.

Market Presence

- Established presence across key North East markets.
- Currently serving customers in Assam, Tripura and Mizoram.
- Expanding through distributors and channel partners.
- Maintains its own social media presence for brand and product communication.

Competitive Position

The business focuses on offering generic products at competitive prices while maintaining product efficacy and quality. It also has a differentiated presence in the North East pharmaceutical market as a women-led, government-recognised startup.

Manufacturing & Operations

- Product manufacturing is outsourced to third-party manufacturing partners.
- Manufacturing partners are located in Panchkula, Ahmedabad, Himachal Pradesh and other locations.
- The business focuses on product development, marketing, distribution and market expansion.

Financial & Funding Details

- Current-year revenue is expected to be approximately ₹1–1.5 Cr.
- The business has previously raised approximately ₹1.5 Cr at a post-money valuation of ₹21.5 Cr.
- The company currently has a bank cash-credit facility.
- The current fundraising is linked to a proposed dilution by one of the existing directors.

Social Initiatives

The business also undertakes CSR activities directly under its own initiative. It is open to exploring collaborations with suitable organisations for future social initiatives.

Investment Opportunity

The company is looking for investors as one of the existing directors intends to dilute part of her shareholding. The investment opportunity provides scope to participate in the next phase of product development, market expansion and distribution growth.

Average Monthly Sales/Revenue (FY 2026-27) : INR 11.50 L

Turnover / Sales (FY 2024-25) : INR 29.00 L

Management, Team & Achievements

- The business is managed by an experienced leadership team with backgrounds in administration, team management, digital presence, public relations and pharmaceutical operations.
- The management team has combined experience ranging from 3 to 15 years across their respective functions.
- The Chief Medical Officer brings around 15 years of experience in the pharmaceutical and healthcare sector.
- The business was recognised as the “Fastest Growing Startup Pharmaceutical Company of the Year 2024.”

Clientele type

The business primarily serves doctors, pharmaceutical wholesale distributors and retail pharmacies.

Premises

OWNED

Premise Size: 2000 sq ft

Market Value (in INR): 2.00 Cr

Asking Price Includes

Proportionate equity shareholding, Board seat / observer rights, Profit-share entitlement, Access to management & books, Pro-rata rights in future rounds, Voting rights

Reason

Reducing personal stake / diversifying

Licenses

Drug Licence, Trade Licence, Shops & Establishment, FSSAI